Oruka Therapeutics, Inc. (ORKA) › Operating Cash FlowOruka Therapeutics, Inc. (ORKA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$8.32M2011: -$6.96M2012: -$4.08M2017: -$17.47M2018: -$8.24M2019: -$4.80M2020: -$7.72M2021: -$18.76M2022: -$10.91M2023: -$5.01M2025: -$88.21M-$88.21M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$88.21M—2023-$5.01M+54.1%2022-$10.91M+41.8%2021-$18.76M-142.9%2020-$7.72M-60.9%2019-$4.80M+41.8%2018-$8.24M+52.8%2017-$17.47M—2012-$4.08M+41.4%2011-$6.96M+16.4%2010-$8.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share